Cargando…
Same but different? A thematic analysis on adalimumab biosimilar switching among patients with juvenile idiopathic arthritis
BACKGROUND: Biologic medications have dramatically enhanced the treatment of many chronic paediatric inflammatory conditions. Their high cost is a factor that prohibits their broader use. Cheaper generic versions, or biosimilars, are increasingly being used. Healthcare services are switching some pa...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778384/ https://www.ncbi.nlm.nih.gov/pubmed/31585539 http://dx.doi.org/10.1186/s12969-019-0366-x |